Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sam Scott

2PUBLICATIONS

21CO-AUTHORS

Gene and molecular therapyAgricultural molecular engineering of nucleic acids and proteins

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Sep 16, 2022

Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.

Brian J Willett, Joe Grove, Oscar A MacLean

|Jul 07, 2022

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.

Brian J Willett, Joe Grove, Oscar A MacLean

Pageof 1

Frequent Collaborators

2 joint publications

Brian J Willett

2 joint publications

Joe Grove

2 joint publications

Craig Wilkie

2 joint publications

Giuditta De Lorenzo

2 joint publications

Wilhelm Furnon

2 joint publications

Shirin Ashraf

2 joint publications

Vanessa Cowton

2 joint publications

Elen Vink

2 joint publications

Lily Tong

2 joint publications

Joseph Hughes

Frequent Collaborators

2 joint publications

Brian J Willett

2 joint publications

Joe Grove

2 joint publications

Craig Wilkie

2 joint publications

Giuditta De Lorenzo

Top Related Videos

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos